Daily summaries

Big-money moves in the US on 04/20 (Mon)

Insider buys
103 trades
Insider sales
246 trades
Congress trades
3 trades

Notable trades of the day

No trade stood out on this day.

Trades disclosed this day

  • Bain Capital Investors

    BuyKailera Therapeutics

    $134.4M

    Filed 04/20

  • Bcpe Perseus Investor

    BuyKailera Therapeutics

    $134.4M

    Filed 04/20

  • Bcpe Perseus Investor GP

    BuyKailera Therapeutics

    $134.4M

    Filed 04/20

  • Bain Capital XIV General Partner

    BuyKailera Therapeutics

    $134.4M

    Filed 04/20

  • Bain Capital Fund XIV

    BuyKailera Therapeutics

    $134.4M

    Filed 04/20

  • Bain Capital Life Sciences IV General Partner

    BuyKailera Therapeutics

    $25M

    Filed 04/20

  • BCLS Fund IV Investments GP

    BuyKailera Therapeutics

    $25M

    Filed 04/20

  • Bain Capital Life Sciences Fund IV

    BuyKailera Therapeutics

    $25M

    Filed 04/20

  • Bain Capital Life Sciences Investors

    BuyKailera Therapeutics

    $25M

    Filed 04/20

  • BCLS Fund IV Investments

    BuyKailera Therapeutics

    $25M

    Filed 04/20

  • Andrew T. Kaplan

    BuyKailera Therapeutics

    $134.4M

    Filed 04/20

  • Illumina Innovation Fund II GP

    BuyAlamar Biosciences

    $4M

    Filed 04/20

  • Illumina Innovation Fund III

    BuyAlamar Biosciences

    $4M

    Filed 04/20

  • Illumina Innovation Fund III GP

    BuyAlamar Biosciences

    $4M

    Filed 04/20

  • Nicholas Naclerio

    BuyAlamar Biosciences

    $4M

    Filed 04/20

  • Illumina Innovation Fund II

    BuyAlamar Biosciences

    $4M

    Filed 04/20

  • Adam Koppel

    BuyKailera Therapeutics

    $25M

    Filed 04/20

  • Lincoln Financial Investments

    BuyLincoln Bain Capital Total Credit Fund

    $25M

    Filed 04/20

  • Nicholas Naclerio

    BuyAlamar Biosciences

    $4M

    Filed 04/20

  • Paulson

    BuyInternational Tower Hill Mines

    $12.6M

    Filed 04/20

  • Broadwood Capital

    BuyInsight Molecular Diagnostics

    $352.1K

    Filed 04/20

  • Broadwood Partners

    BuyInsight Molecular Diagnostics

    $352.1K

    Filed 04/20

  • Neal C. Bradsher

    BuyInsight Molecular Diagnostics

    $352.1K

    Filed 04/20

  • Jason Aaron Roth

    BuyArxis

    $1.7M

    Filed 04/20

  • Broadwood Partners

    BuyInsight Molecular Diagnostics

    $157.9K

    Filed 04/20

  • Broadwood Capital

    BuyInsight Molecular Diagnostics

    $157.9K

    Filed 04/20

  • Neal C. Bradsher

    BuyInsight Molecular Diagnostics

    $157.9K

    Filed 04/20

  • Kevin Scott Perhamus

    BuyArxis

    $1.5M

    Filed 04/20

  • Broadwood Capital

    BuyInsight Molecular Diagnostics

    $143.2K

    Filed 04/20

  • Broadwood Partners

    BuyInsight Molecular Diagnostics

    $143.2K

    Filed 04/20

  • Neal C. Bradsher

    BuyInsight Molecular Diagnostics

    $143.2K

    Filed 04/20

  • Azad Sid Badakhsh

    BuyArxis

    $1M

    Filed 04/20

  • Brian Raduenz

    BuyAevex

    $1M

    Filed 04/20

  • John W. Allison

    BuyHome Bancshares

    $2.7M

    Filed 04/20

  • Stephen Duane Oetgen

    BuyArxis

    $700K

    Filed 04/20

  • Rainey E. Lancaster

    BuyAmrep

    $41.4K

    Filed 04/20

  • James H. Dahl

    BuyAmrep

    $41.4K

    Filed 04/20

  • Ross Bradley Sealfon

    BuyArxis

    $350K

    Filed 04/20

  • Patrick E. Allen

    BuyArxis

    $280K

    Filed 04/20

  • James H. Dahl

    BuyAmrep

    $27.7K

    Filed 04/20

  • Rainey E. Lancaster

    BuyAmrep

    $27.7K

    Filed 04/20

  • Brett P. Hush

    BuyAevex

    $200K

    Filed 04/20

  • Ryan Anthony Jankowski

    BuyArxis

    $125K

    Filed 04/20

  • John Brendan Doyle

    BuyCognition Therapeutics

    $11.3K

    Filed 04/20

  • Lori Love

    BuyBitmine Immersion Technologies

    $10.5K

    Filed 04/20

  • Lisa Ricciardi

    BuyCognition Therapeutics

    $10.1K

    Filed 04/20

  • Lori Love

    BuyBitmine Immersion Technologies

    $4,996

    Filed 04/20

  • $10K

    Filed 04/20

  • Neal C. Bradsher

    BuyInsight Molecular Diagnostics

    $0

    Filed 04/20

  • Broadwood Partners

    BuyInsight Molecular Diagnostics

    $0

    Filed 04/20